Lifeist Wellness announced that its U.S. biosciences subsidiary Mikra Cellular Sciences has begun commercial scale production of a new and improved version of CELLF.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NXTTF:
- Mikra Commences Commercial Scale Production of Upgraded CELLF
- Lifeist’s Cannmart to introduces multi-pack cannabis products in Ontario
- Lifeist’s CannMart Brings First-to-Market Multi-Pack Cannabis Products to Ontario
- Lifeist’s Mikra to begin production on nutritional bars in late spring 2023
- Lifeist’s Subsidiary Mikra to Sell CELLF in 5,000+ GNC Stores Across the U.S.